CD5 and diffuse large B-cell lymphoma: CD30 expression, frequently seen in the anaplastic variant of DLBCL [33,34], has been shown to be associated with a favorable outcome [34], while CD5-positive cases exhibit features associated with an aggressive clinical course and poorer survival [35].